Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simultaneous Disruption of Latency and Immune Enhancement by Poly-ICLC During HIV-1 Infection

NCT02071095 is registered in ClinicalTrials.gov with Nina Bhardwaj as lead sponsor.

NCT NCT02071095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02071095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simultaneous Disruption of Latency and Immune Enhancement by Poly-ICLC During HIV-1 Infection
Lead sponsor
Nina Bhardwaj
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2014
Completion date
July 26, 2016
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infected adults with chronic hiv-1 infection